Fenofibrate 50 MG Oral Capsule [Lipofen] — RxCUI 702169
RxNorm drug concept · Semantic branded drug
RxCUI 702169
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI702169
Official nameFenofibrate 50 MG Oral Capsule [Lipofen]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLipofen 50 MG Oral Capsule
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)66 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fenofibrate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It helps lower triglycerides, and in some products LDL cholesterol, while raising HDL in some cases. It works alongside a healthy diet, not instead of one. Which uses apply depends...
- It depends on the product. Tricor tablets and some capsules like Antara can be taken with or without food, while Lipofen should be taken with food. Check your label or ask me, and...
- Common ones include abdominal pain, back pain, headache, nausea, constipation and a stuffy nose. It can also raise liver enzymes, which is why you will need blood tests.
- Call right away for muscle pain or weakness, dark urine, yellow skin or eyes, severe belly pain, or leg swelling and chest pain. Seek emergency help for facial swelling, trouble br...
🕸️ Concept Web — How Fenofibrate 50 MG Oral Capsule [Lipofen] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Fenofibrate 50 MG Oral Capsule [Lipofen]
RxCUI 702169 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Fenofibrate
8703IN
-
Fenofibrate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Lipofen
615906BN
-
Lipofen
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Fenofibrate Oral Capsule
379815SCDF -
Fenofibrate Oral Product
1159042SCDG -
Fenofibrate Pill
1159043SCDG -
Fenofibrate Oral Capsule [Lipofen]
702052SBDF -
Lipofen Oral Product
1177402SBDG -
Lipofen Pill
1177403SBDG -
Oral Capsule
316965DF -
Oral Product
1151131DFG - +1 more in this family
-
Fenofibrate Oral Capsule
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Fenofibrate 50 MG Oral Capsule
616853SCD -
Fenofibrate 50 MG
577030SCDC -
Fenofibrate 50 MG [Lipofen]
702168SBDC
-
Fenofibrate 50 MG Oral Capsule
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Fenofibrate 50 MG Oral Capsule
SCD · 616853 -
Fenofibrate 50 MG
SCDC · 577030 -
Fenofibrate Oral Capsule
SCDF · 379815 -
Fenofibrate Oral Product
SCDG · 1159042 -
Fenofibrate Pill
SCDG · 1159043
Brand-Name Concepts
-
Fenofibrate 50 MG [Lipofen]
SBDC · 702168 -
Fenofibrate Oral Capsule [Lipofen]
SBDF · 702052 -
Lipofen Oral Product
SBDG · 1177402 -
Lipofen Pill
SBDG · 1177403 -
Lipofen
BN · 615906
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 702169 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 62559-0305-90 | 90 CAPSULE in 1 BOTTLE (62559-305-90) | Lipofen | ANI Pharmaceuticals, Inc. | 2021-09-24 |
| 62559-0306-90 | 90 CAPSULE in 1 BOTTLE (62559-306-90) | Lipofen | ANI Pharmaceuticals, Inc. | 2021-09-24 |
Observed labelers:
ANI Pharmaceuticals, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.